Press/Media
- 175 - 200 out of 822 results
Search results
-
Model Medicines Announces AI-Discovered Oral Antiviral Therapeutic, MDL-001, Has Demonstrated Potential Best-In-Class Combination Of Viral Load Reduction, Symptom Reduction, Activity Against SARS-CoV-2 Variants And Pan Antiviral Activity
Kris White, & Adolfo Garcia-Sastre,
20/05/22
1 item of Media coverage
Press/Media
-
Model Medicines Announces AI-Discovered Oral Antiviral Therapeutic, MDL-001, Has Demonstrated Potential Best-In-Class Combination of Viral Load Reduction, Symptom Reduction, Activity Against SARS-CoV-2 Variants and Pan Antiviral Activity.
Kris White, & Adolfo Garcia-Sastre,
17/05/22
35 items of Media coverage
Press/Media
-
AUA: Immunotherapy Aids Survival in Muscle-Invasive Bladder Cancer
17/05/22
81 items of Media coverage
Press/Media
-
Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival
16/05/22
1 item of Media coverage
Press/Media
-
Dr. Galsky on Updated CheckMate 274 Data With Adjuvant Nivolumab in Urothelial Carcinoma
15/05/22
1 item of Media coverage
Press/Media
-
UROLOGISTS EXPLORE THE ROLE OF ROBOTICS, EQUITY, EXERCISE AND MEDICINE ON BLADDER CANCER
14/05/22
1 item of Media coverage
Press/Media
-
Immunotherapy after bladder cancer surgery shows excellent cancer-free survival rates
14/05/22
2 items of Media coverage
Press/Media
-
Urologists Explore The Role Of Robotics, Equity, Exercise And Medicine On Bladder Cancer'
14/05/22
1 item of Media coverage
Press/Media
-
Two Leading Mount Sinai Brain Scientists Elected to the National Academy of Sciences
Eric Nestler, Adolfo Garcia-Sastre,, Helen Mayberg, & Miriam Merad
5/05/22
2 items of Media coverage
Press/Media
-
Third Dose of COVID-19 Vaccine Significantly Increases Immune Responses in Most Patients With Multiple Myeloma
4/05/22
1 item of Media coverage
Press/Media
-
Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection
Honoratus Van Bakel, Adolfo Garcia-Sastre,, Viviana Simon, Randy Albrecht, & Michael Schotsaert
31/03/22 → 8/04/22
3 items of Media coverage
Press/Media
-
Third Dose of COVID-19 Vaccine Significantly Increases Immune Responses in Most Patients With Multiple Myeloma
6/04/22 → 8/04/22
13 items of Media coverage
Press/Media
-
Third dose of COVID-19 vaccine significantly increases immune responses in most patients with multiple myeloma
6/04/22 → 7/04/22
8 items of Media coverage
Press/Media
-
Mount Sinai Health System: Third Dose of COVID-19 Vaccine Significantly Increases Immune Responses in Most Patients With Multiple Myeloma
6/04/22
1 item of Media coverage
Press/Media
-
U.S. Patents Awarded to Inventors in New Jersey (April 2)
Kiyotake Ishikawa & James Ferrara
2/04/22
2 items of Media coverage
Press/Media
-
NIH program provides a real-time risk assessment of variants of SARS-CoV-2
Honoratus Van Bakel, Adolfo Garcia-Sastre,, Viviana Simon, Randy Albrecht, & Michael Schotsaert
1/04/22
2 items of Media coverage
Press/Media
-
Column: Cancer Touches Everyone – Join a Cancer Conversation on March 30
18/03/22
1 item of Media coverage
Press/Media
-
New Orleans partnership aims to cure cancer that kills twice as many Black people
18/03/22
1 item of Media coverage
Press/Media
-
-
Novel CRISPR Imaging Technology Reveals Genes Controlling Tumor Immunity
Brian Brown & Miriam Merad
15/03/22
1 item of Media coverage
Press/Media
-
Living with SARS-CoV-2: Three Leading Microbiologists Discuss the Path Forward
Adolfo Garcia-Sastre,, Florian Krammer, & Peter Palese
8/03/22
1 item of Media coverage
Press/Media
-
SARS-CoV-2: Three Leading Microbiologists Discuss the Path Forward
Adolfo Garcia-Sastre,, Florian Krammer, & Peter Palese
8/03/22
1 item of Media coverage
Press/Media
-
Experts debate whether peanut sensitization can occur through the respiratory tract
28/02/22
1 item of Media coverage
Press/Media